Literature DB >> 7508874

Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes.

M Vaxillaire1, N Vionnet, C Vigouroux, F Sun, R Espinosa, M M Lebeau, M Stoffel, M Lehto, J S Beckmann, M Detheux.   

Abstract

Maturity-onset diabetes of the young (MODY) is a model for genetic studies of non-insulin-dependent diabetes mellitus. We have identified 15 MODY families in which diabetes is not the result of mutations in the glucokinase gene. This cohort of families will be useful for identifying other diabetes-susceptibility genes. Nine other candidate genes potentially implicated in insulin secretion or insulin action have been tested for linkage with MODY in these families, including glucokinase regulatory protein, hexokinase II, insulin receptor substrate 1, fatty acid-binding protein 2, glucagon-like peptide-1 receptor, apolipoprotein C-II, glycogen synthase, adenosine deaminase (a marker for the MODY gene on chromosome 20), and phosphoenolpyruvate carboxykinase. None of these loci showed evidence for linkage with MODY, implying that mutations in these genes do not make a major genetic contribution to the development of MODY. In addition to these linkage analyses, one or two affected subjects from each family were screened for the presence of the A to G mutation at nucleotide 3,243 of the mitochondrial tRNA(Leu(UUR)) gene. This mutation was not found in any of these subjects. Finally, we report the localization of the gene encoding the regulatory protein of glucokinase to chromosome 2, band p22.3 and the identification of a restriction fragment length polymorphism at this locus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508874     DOI: 10.2337/diab.43.3.389

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians.

Authors:  H Ardehali; G E Tiller; R L Printz; H Mochizuki; M Prochazka; D K Granner
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

2.  Exclusion of adenosine deaminase gene locus on chromosome 20q12-13.1 in familial NIDDM in Taiwanese patients.

Authors:  L M Chuang; K C Chiu; H P Wu; T S Jou; T Y Tai; B J Lin
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 3.  Glucagon-like peptide 1 (GLP-1) and metabolic diseases.

Authors:  C M Rotella; L Pala; E Mannucci
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

4.  Detection of mitochondrial DNA mutations in patients with diabetes mellitus.

Authors:  A W Thomas; R Morgan; A Majid; A Rees; J C Alcolado
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

5.  Candidate gene studies in pedigrees with maturity-onset diabetes of the young not linked with glucokinase.

Authors:  Y Zhang; M Warren-Perry; P J Saker; A T Hattersley; A D Mackie; J D Baird; R H Greenwood; M Stoffel; G I Bell; R C Turner
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

6.  Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity.

Authors:  M Lehto; X Huang; E M Davis; M M Le Beau; E Laurila; K F Eriksson; G I Bell; L Groop
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

7.  Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23.

Authors:  B E Hayward; J A Fantes; J P Warner; S Intody; J P Leek; A F Markham; D T Bonthron
Journal:  Mamm Genome       Date:  1996-06       Impact factor: 2.957

8.  Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization.

Authors:  J P Warner; J P Leek; S Intody; A F Markham; D T Bonthron
Journal:  Mamm Genome       Date:  1995-08       Impact factor: 2.957

9.  Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians.

Authors:  M Veiga-da-Cunha; J Delplanque; A Gillain; D T Bonthron; P Boutin; E Van Schaftingen; P Froguel
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.